Pi-Cardia wins FDA breakthrough nod for leaflet modification device
Pi-Cardia announced today that the FDA granted breakthrough device designation for its ShortCut leaflet modification device.
Source: massdevice.com
Stay updated with breaking news from Shortcut Mitral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pi-Cardia announced today that the FDA granted breakthrough device designation for its ShortCut leaflet modification device.
Pi-Cardia announced today that it completed a successful first-in-human treatment of the mitral valve with its ShortCut device.